Keywords: biosante, reacquires, elestrin, rights, usa-based, pharmaceuticals, says

BioSante reacquires Elestrin rights

Article | 18 August 2008

Print This

USA-based BioSante Pharmaceuticals says that it has reacquired Elestrin (estradiol gel) from Nycomed US, a unit of the Danish firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in